Riley Anthony L, Hempel Briana J, Clasen Matthew M
Psychopharmacology Laboratory, Center for Behavioral Neuroscience, American University, 4400 Massachusetts Ave, NW, Washington, D.C. 20016, USA.
Psychopharmacology Laboratory, Center for Behavioral Neuroscience, American University, 4400 Massachusetts Ave, NW, Washington, D.C. 20016, USA.
Physiol Behav. 2018 Apr 1;187:79-96. doi: 10.1016/j.physbeh.2017.10.005. Epub 2017 Oct 13.
The study of sex as a biological variable is a necessary emphasis across a wide array of endpoints, including basic neuroscience, medicine, mental health, physiology and behavior. The present review summarizes work from clinical and preclinical populations on sex differences in drug use and abuse, ranging from initiation to escalation/dysregulation and from drug cessation/abstinence to relapse. These differences are analyzed in the context of the addiction cycle conceptualization of Koob and his colleagues and address patterns of drug use (binge/intoxication), motivation underlying its use (withdrawal/negative affect) and likelihood and causes of craving and relapse of drug taking (preoccupation/anticipation). Following this overview, an assessment of the basis for the reported sex differences is discussed in the context of the affective (rewarding and aversive) properties of drugs of abuse and how such properties and their balance vary with sex and contribute to drug intake. Finally, the interaction of sex with several experiential (drug history) and subject (age) factors and how these interactions affect reward and aversion are discussed to highlight the importance of understanding such interactions in predicting drug use and abuse. We note that sex as a biological variable remains one of critical evaluation and that such investigations of sex differences in drug use and abuse continue and be expanded to assess all facets of their mediation, including these affective properties, how their balance may be impacted by the multiple conditions under which drugs are taken and how this overall balance affects drug use and addiction vulnerability.
将性别作为一个生物学变量进行研究,对于包括基础神经科学、医学、心理健康、生理学和行为学在内的众多研究终点而言,都是一项必要的重点工作。本综述总结了临床和临床前人群中关于药物使用和滥用方面性别差异的研究成果,范围涵盖从药物起始使用到升级/失调,以及从停药/戒断到复发的整个过程。这些差异在库布及其同事提出的成瘾循环概念框架下进行分析,涉及药物使用模式(暴饮暴食/中毒)、使用药物的潜在动机(戒断/负面情绪)以及药物渴求与复发的可能性和原因(专注/预期)。在此概述之后,将在滥用药物的情感属性(奖赏性和厌恶性)背景下,讨论所报道的性别差异的基础,以及这些属性及其平衡如何随性别变化并影响药物摄入。最后,将讨论性别与几个经验性(用药史)和主体(年龄)因素的相互作用,以及这些相互作用如何影响奖赏和厌恶,以强调理解此类相互作用在预测药物使用和滥用方面的重要性。我们注意到,将性别作为一个生物学变量仍然是关键的评估内容之一,对药物使用和滥用方面性别差异的此类研究将继续并得到扩展,以评估其介导作用的所有方面,包括这些情感属性、药物使用的多种条件如何可能影响其平衡,以及这种整体平衡如何影响药物使用和成瘾易感性。